Prioritizing LDL-Cholesterol Control

Publication

Article

September 9, 2024

Supplements and Featured Publications

Volume

LDL cholesterol management is vital for reducing cardiovascular disease risk and improving patient outcomes through effective lipid-lowering therapies.
Advancements in therapies, such as PCSK9 inhibitors and statins, have significantly reduced LDL levels, enhancing cardiovascular health.
Personalized treatment strategies, considering genetic predispositions and comorbidities, are essential for optimizing therapeutic outcomes.
Ongoing research explores novel therapeutic targets and strategies to further improve LDL cholesterol management and cardiovascular health.

This supplement highlights the critical role of LDL cholesterol management in reducing cardiovascular disease and improving outcomes.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512